252 related articles for article (PubMed ID: 33221436)
1. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM
Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436
[TBL] [Abstract][Full Text] [Related]
2. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
3. Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.
Li M; Andersson-Lendahl M; Sejersen T; Arner A
FASEB J; 2014 Apr; 28(4):1593-9. PubMed ID: 24371125
[TBL] [Abstract][Full Text] [Related]
4. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
5. Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.
Vieira NM; Elvers I; Alexander MS; Moreira YB; Eran A; Gomes JP; Marshall JL; Karlsson EK; Verjovski-Almeida S; Lindblad-Toh K; Kunkel LM; Zatz M
Cell; 2015 Nov; 163(5):1204-1213. PubMed ID: 26582133
[TBL] [Abstract][Full Text] [Related]
6. The golden retriever model of Duchenne muscular dystrophy.
Kornegay JN
Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
[TBL] [Abstract][Full Text] [Related]
7. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
Waugh TA; Horstick E; Hur J; Jackson SW; Davidson AE; Li X; Dowling JJ
Hum Mol Genet; 2014 Sep; 23(17):4651-62. PubMed ID: 24760771
[TBL] [Abstract][Full Text] [Related]
9. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E
Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375
[TBL] [Abstract][Full Text] [Related]
10. X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.
Barthélémy I; Calmels N; Weiss RB; Tiret L; Vulin A; Wein N; Peccate C; Drougard C; Beroud C; Deburgrave N; Thibaud JL; Escriou C; Punzón I; Garcia L; Kaplan JC; Flanigan KM; Leturcq F; Blot S
Skelet Muscle; 2020 Aug; 10(1):23. PubMed ID: 32767978
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
[TBL] [Abstract][Full Text] [Related]
12. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
[TBL] [Abstract][Full Text] [Related]
13. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy.
Birch SM; Lawlor MW; Conlon TJ; Guo LJ; Crudele JM; Hawkins EC; Nghiem PP; Ahn M; Meng H; Beatka MJ; Fickau BA; Prieto JC; Styner MA; Struharik MJ; Shanks C; Brown KJ; Golebiowski D; Bettis AK; Balog-Alvarez CJ; Clement N; Coleman KE; Corti M; Pan X; Hauschka SD; Gonzalez JP; Morris CA; Schneider JS; Duan D; Chamberlain JS; Byrne BJ; Kornegay JN
Sci Transl Med; 2023 Jan; 15(677):eabo1815. PubMed ID: 36599002
[TBL] [Abstract][Full Text] [Related]
14. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
16. Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.
Echigoya Y; Nakamura A; Nagata T; Urasawa N; Lim KRQ; Trieu N; Panesar D; Kuraoka M; Moulton HM; Saito T; Aoki Y; Iversen P; Sazani P; Kole R; Maruyama R; Partridge T; Takeda S; Yokota T
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4213-4218. PubMed ID: 28373570
[TBL] [Abstract][Full Text] [Related]
17. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
[TBL] [Abstract][Full Text] [Related]
18. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
[TBL] [Abstract][Full Text] [Related]
19. Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid.
Licitra R; Marchese M; Brogi L; Fronte B; Pitto L; Santorelli FM
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808773
[TBL] [Abstract][Full Text] [Related]
20. Drug screening in a zebrafish model of Duchenne muscular dystrophy.
Kawahara G; Karpf JA; Myers JA; Alexander MS; Guyon JR; Kunkel LM
Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5331-6. PubMed ID: 21402949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
